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Oxymyoglobin at ‘physiological’ concentrations of 20-100 micromolar protected cultured endothelial cells from damage by xanthinelxanthine 
oxidase or by hydrogen peroxide. Metmyoglobin also provided a degree of protection, but apomyoglobin was ineffective. Protectton was enhanced 
in the presence of ascorbate (0.01-l mM). Myoglobin may have a physiological role m the protection of muscular tissue from ischaemialreperfusion- 
induced damage. 
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1. INTRODUCTION 
Oxygen-containing free radicals have been exten- 
sively discussed as potential intermediates in tissue 
damage associated with reperfusion after ischaemia. 
There is general agreement hat externally generated 
free radicals cause damage [l,Z], but results of experi- 
ments designed to detect free radical generation under 
ischaemia-reperfusion conditions or to show protection 
against injury by free radical scavenging agents have 
been less consistent [3-51. Myoglobin is a ubiquitous 
muscle protein present in particularly high concentra- 
tion {up to 300 micromolar) in cardiac or ‘red’ skeletal 
muscle. Its classical role is to facilitate intracellular ox- 
ygen transport at low oxygen tensions. As a heme pro- 
tein, myoglobin will also interact with hydrogen perox- 
ide and oxygen radical generating systems in a variety 
of ways [6-81; it is unclear from a-priori reasoning 
whether these interactions are protective, irrelevant or 
actually harmful. We used cultured endothelial cells, 
which are known to be sensitive to oxygen free radical- 
induced damage, as a marker system to investigate 
whether physiological concentrations of myoglobin 
would enhance or protect against damage induced by 
xanthinelxanthine oxidase or hydrogen peroxide. 
2. MATERIALS AND METHODS 
Hydrogen peroxide was diluted from 30% stock solution (Sigma). 
Hydrogen peroxide concentration was measured by KM&, titration 
or by horseradish peroxidase catalysed oxidations [9]. Superoxide 
anion (plus hydrogen peroxide) was generated by mixing 0.4 mM 
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xanthine (sodium salt. Stgma) wtth 0.04 U/ml xanthine oxidase (Grade 
III, Sigma). Catalase (from bovine liver). superoxide dismutase (from 
bovine liver), horseradish peroxidase and L-ascorbic acid were pur- 
chased from Sigma. 
Metmyoglobin (type III, from horse heart) and apomyoglobm were 
purchased from Sigma and purified on Sephadex G50 before use. 
Sigma apomyoglobln may be toxic to endothelial cells, but the toxicity 
was abolished by dialysis against Hanks solution. Toxicity was not 
seen with apomyoglobin prepared by acid-acetone precipitation [IO] 
in our laboratory. Oxymyoglobm was prepared by adding an excess 
of sodium dithiomte (Sigma) m the presence of an. and purified on 
a Sephadex G50 column. All commercially obtamed protems were 
assayed for contammating catalase activity, but this is impracticable 
for oxy- or metmyoglobm smce they have mtrmsic ‘catalase-like’ activ- 
ity In order to be sure that the apparent protective ffect of myoglobin 
was not m fact due to contammating catalase. we therefore reconsti- 
tuted metmyoglobin from apomyoglobin and hemm [lo], neither of 
which exhibtted catalase-like activity alone. 
Optrcal densities were measured using an Silo spectrophotometer 
(WPA). The amounts of met-. oxy- and ferrylmyoglobm were deter- 
mined by making measurements at490. 560 and 580 nm and applying 
the following equations [6,7,11]: 
[Oxymyoglobin] = 2.8.Ahy,, - 127.AS,, 
[Metmyoglobin] = 146.Aa9, - 108.A,, + 2.l.A,,, 
[Ferrylmyoglobm] = -62.A,,, + 242.A4,, - 123,A,, 
Endothelial cells isolated from bovine aorta were cultured in Dul- 
becco’s modified Eagle’s m~ium supplemented with 10% newborn 
calf serum. They were cloned at first subculture [12], s&cultured to 
15 mm diameter wells in multiwell trays and used at confluence, 
approximately 1.8 x 10’ per well. Before use, culture medium was 
removed and the cells washed with Hanks’ solution (without Phenol 
red). Reagents were added to the cells in the order: Hanks’ solution; 
ascorbic acid (0.01-I mM) or catalase (IO3 U/ml) or superoxide dis- 
mutase (100 U/ml); myoglobin (0.01-0.1 mM); xanthine/xanthine ox- 
tdase or hydrogen peroxide. Ail concentrations were final concentra- 
tions in a reaction volume of 1 ml. 8 replicates were used per experi- 
ment. Unless otherwise stated, incubation with hydrogen peroxide or 
xanthmelxanthine oxtdase was for 4 h at 37°C. 
Damage to target endothelial cells was assessed by two methods: 
(i) Tritiated adenine release assay: endothelial cells were loaded with 
[U-“Hladenine by incubation for 24 h in culture medium containing 
0.037MBqlml [‘Hladenine (Amersham), washed three times with 
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Fig. 1. Effect of oxymyoglobin on endothelial integrity measured as 
content of trrtiated adenine (pM per 10’ cells, bars=S.D.) after treat- 
ment with xanthine/xanthine oxidase. (A) Control; (B) plus xanthine 
0.4 mM and xanthine oxidase 0.04 U/ml; (C) xanthine/xanthme oxi- 
dase + 10 micromolar oxymyoglobm; (D) xanthine/xanthine oxidase 
+ 20 micromolar oxymyoglobin; (E) xanthine/xanthine oxidase + 50 
mtcromolar oxymyoglobin; (F) xanthine/xanthine oxidase + 100 mi- 
cromolar oxymyoglobin; (G) xanthine/xanthine oxidase + 100 micro- 
molar apomyoglobm; (H) xanthine/xanthine oxidase + superoxide 
dismutase; (I) xanthine/xanthine oxidase + catalase; (J) xanthine/ xan- 
thine oxidase + superoxide dismutase + catalase. 
Hanks solution, then incubated for 4 h with xanthine/xanthine oxidase 
or hydrogen peroxrde. Cells were again washed three times with 
Hanks, lysed in 2 N NaOH, and the lysate counted using Biofluor 
(NEN) scintillant and a TrKarb 1500 liquid scintillation analyzer. 
(ii) Terminal adenine uptake assay [1 I]. Unlabelled endothelial cells 
were first treated with hydrogen peroxide and other reagents as de- 
scribed above. The endothelial cell monolayer was washed three times 
with Hanks’ solution and incubated for a further hour with Hanks 
solution containing 5 mM glucose and 0.037 MBqlml [‘Hladenine. 
Cells were again washed three times, and then lysed and counted as 
described above. 
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Fig. 3. Effect of oxymyoglobin on endothelial function as assessed by 
terminal ademne uptake assay. Cells were first treated with 1 mM 
hydrogen peroxide and then Incubated with [‘Hladenine. Ademne 
uptake expressed as pM per 10’ cells. (A) Normal control; (B) hydro- 
gen peroxide 1 mM; (C-F) hydrogen peroxide 1 mM with oxymyo- 
globin 10. 20. 50 and 100 PM, respectively; (G) hydrogen peroxide + 
catalase 10’ U/ml. 
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Fig. 2. Effect of ascorbate on endothelial protection measured a 
[“Hladenine content by oxymyoglobin in the presence of 1 mM hydro- 
gen peroxide. (A) Normal control; (B) 1 mM hydrogen peroxide: (C) 
hydrogen peroxide 1 mM + oxymyoglobm 100pM; (D) C + ascorbate 
0.01 mM; (E) C + ascorbate 0.1 mM; (F) C + 1 mM ascorbate; (G) 
ascorbate 1 mM. 
Endothelial damage was also monitored by phase contrast micros- 
copy after incubation with 0.1% Trypan blue. 
3. RESULTS 
Oxymyoglobin or metmyoglobin reduced tritiated 
adenine release from preloaded cells exposed to hydro- 
gen peroxide or xanthinelxanthine oxidase in a dose- 
related manner (Fig. 1, Table I). Catalase was protec- 
tive, but superoxide dismutase was not. Apomyoglobin 
had no protective effect. Adding ascorbic acid enhanced 
Table I 
Effect of oxymyoglobm, metmyoglobin and ascorbrc acid on endothe- 
lial cells adenine retention after exposure to 1 mM hydrogen peroxrde 
Conditrons 
Control 
Hydrogen peroxrde 
Hydrogen peroxide plus: 
10 PM Oxymyoglobin 
10 PM Metmyoglobin 
20 PM Oxymyoglobin 
20 ,I.LM Metmyoglobin 
20 PM Oxymyoglobin 
+ 1 mM ascorbate 
100 PM Oxymyoglobin 
100 PM Metmyoglobin 
100 PM Apomyoglobm 
100 PM Oxymyoglobin 
+ 1 mM ascorbate 
Catalase 1.000 U/ml 
Ademne content 
(pM/lO’ cells) 
Standard deviatron 
20 
2.2 
3.8 0.6 
4.1 0.8 
7.1 0.5 
7.1 1.1 
16.6 0.7 
13.0 0.8 
12.9 0.9 
2.3 06 
16.1 0.8 
19.4 1.1 
0.9 
0.5 
Results are mean of 8 replicates 
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Fig. 4. Phase contrast micrographs (ma~ification x100) showing cytotoxic effect of 1 mM hydrogen peroxide (a) and protection in the presence 
of 100 micromolar oxymyoglobin (b). 
the protective effect of met- or ox~yoglobin, but 
ascorbic acid was ineffective in the absence of myo- 
globin (Fig. 2). These results were replicated using a 
terminal adenine uptake assay (Fig. 3). Protection by 
myo~obin was also confirmed by phase contrast mi- 
croscopy (Fig. 4). Native myoglobin and myoglobin 
reconstituted from apomyoglobin and hemin had iden- 
tical effects. Ascorbate did not potentiate the protective 
effect of catalase. 
During the course of the incubation, oxymyoglobin 
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Fig. 5. Effect on myoglobin of incubation with xanthine 0.4 mM and 
xanthine oxidase 0.04 U/ml at 25°C. Concentrations (mlcromolar) I
min after mixing were oxymyoglobin 19.0, metmyoglobm 0.6, fer- 
rylmyoglobin 1.2, total (heme) 20.7. After 60 min concentrations were 
oxymyoglobin 1.1. metmyoglobm 17.4, ferrylmyoglobin 0.2, total 
(heme) 18.7. 
was converted to metmyoglobin with the intermediate 
formation of ferrylmyoglobin (Fig. 5). Calculated loss 
of heme under these conditions was approximately 10%. 
4. DISCUSSION 
The interactions of myoglobin and haemoglobin with 
hydrogen peroxide have been extensively studied. Previ- 
ous workers have tended to emphasise the potential role 
of heme proteins in generating, rather than scavenging, 
oxygen-containing radicals, either directly or through 
the release of free iron [14,15]. More recently, Giulivi 
and Davies described the ‘comproportionation’ of fer- 
rylhemoglobin and oxyhemoglobin as a potential anti- 
oxidant and free radical scavenging mechanism [16]. A 
similar reaction between oxy- and ferrylmyoglobin had 
earlier been described by Whitburn [6]. Walters, Ken- 
nedy and Jones [17] described the oxidation of myo- 
globin in isolated myocytes by 15-hydroperoxy- 
5,811 .13 eicosatetraenoic acid, but considered this as a 
marker of oxidative stress rather than a protective 
mechanism. Galaris, Cadenas and Hochstein [18] de- 
scribed redox ‘cycling’ of myoglobin and ascorbate and 
speculated that this might act as a defence mechanism. 
but did not demonstrate this effect in a biological sys- 
tem. More recently, Ozawa and Koreswka [ 191 de- 
scribed a non- specific oxidase activity of myoglobin 
after exposure to hydrogen peroxide. We have found 
that oxy- or metmyoglobin (but not apomyoglobin) 
markedly accelerate the decay of the ESR signal of the 
hydroxyl radical adduct of 5,5’ dimethyl-1-pyrroline-N- 
oxide (DMPO), and have tentatively ascribed this to 
further oxidation to non-paramagnetic products [20]. 
In our system we found that both oxy- and metmyo- 
globin in ‘physiological’ concentrations provide partial 
protection against endothelial membrane damage 
caused by external oxygen free radical generating sys- 
tems and hydrogen peroxide. We chose endothelial cells 
as targets because they are known to be particularly 
sensitive to oxygen free radical-mediated damage [21] 
and because they do not contain myoglobin. 
A non-specific radical scavenging effect can be ruled 
out by the lack of efficacy of apomyoglobin. The tran- 
sient generation of ferrylmyoglobin, and subsequent 
conversion to metmyoglobin, under the conditions we 
used would be compatible with a peroxide-scavenging 
‘comproportionation’ reaction as part of the mecha- 
nism in the case of oxymyoglobin, but would not ex- 
plain the protective effect of metmyoglobin alone. In the 
presence of myoglobin hydrogen peroxide will oxidise 
ascorbate [18]. Ascorbate probably reacts with fer- 
rylmyoglobin as well as with metmyoglobin. 
Provided the supply of ascorbate (or equivalent re- 
ducing agent) is adequate, the net effect will be protec- 
tive. The reactions involved have been well reviewed by 
Arduini and Hochstein [22], although we would place 
a different emphasis on the likelihood of MB (Fe”OH) 
oxidising a low molecular weight electron donor rather 
than important structural components of the cell (Fig. 6) 
The mechanism of the protective effect in the absence 
of ascorbate is less clear, and may involve sacrificial 
auto-oxidation with loss of the heme group. Potential 
toxicity resulting from the release of iron from free 
heme [11,23] might explain why, even in high concentra- 
tions, the protection offered by oxy- or metmyoglobin 
alone was less complete than with catalase. 
In our model superoxide dismutase had no effect ei- 
ther on the formation of ferrylmyoglobin or on cell 
damage. This accords with other reports that hydrogen 
peroxide, or more probably hydroxyl radicals, are the 
crucial species, and that the conversion of superoxide 
anion to hydrogen peroxide is not rate limiting [24,25]. 
The initial concentration of hydrogen peroxide we used 
in some of our experiments, 1 mM, is large in compar- 
ison with concentrations used by some other authors, 
but hydrogen peroxide concentration falls rapidly under 
the incubation conditions used. and we wished to model 
the effects of sudden exposure to large hydrogen perox- 
148 
Volume 319. number 1,2 FEBS LETTERS 
Antioxidant, 
March 1993 
$ 
Damage ? 
Fig. 6. Suggested reaction schemes for myoglobin. Metmyoglobin (Fe-“), oxymyoglobin and deoxymyoglobin (Fe*‘) can all be oxidized to 
ferrylmyoglobin (Fe4) by hydrogen peroxide. Ferrylmyoglobin may cornproportionate with oxymyoglobin, or may be reduced to metmyoglobm 
by reacting with a low molecular weight electron donor such as ascorbate. 
ide concentrations as a possible consequence of reperfu- 
sion after ischaemia. Continuous production of hydro- 
gen peroxide. whether by xanthinefxanthine oxidase or 
by activated polymorphs, is more damaging to cells 
even when steady-state concentrations are much lower; 
we found that myoglobin was protective under both sets 
of conditions. Endothelial cells are capable of produc- 
ing nitric oxide, and it has been suggested that peroxyni- 
trite formed from superoxide and nitric oxide is a partic- 
ularly damaging species 1261. Heme proteins are good 
scavengers of nitric oxide, and this is another potential 
mechanism for protection. 
Myoglobin in our system clearly has an overall pro- 
tective effect on endothelium in the presence of oxida- 
tive stress, and was indeed necessary for the protective 
effect of biological antioxidants uch as ascorbate. This 
is despite its facilitation of hydrogen peroxide mediated 
oxidative reactions: possibiy because myoglobin selec- 
tively catalyses oxidation of ‘expendable’ small mole- 
cules rather than important membrane components. 
Myoglobin occurs physiologically in cell types which 
are continually exposed to extremes of ischaemia and 
reoxygenation, and has been highly conserved in evolu- 
tion. The possibility that, exceptionally, it may act as a 
‘double-edged sword’ cannot be discounted, but we sug- 
gest that it may have a physiological role in protection 
against oxygen free radical-mediated amage 
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